Nurix Therapeutics Inc.

NASDAQ: NRIX · Real-Time Price · USD
10.57
0.01 (0.09%)
At close: Aug 15, 2025, 3:59 PM
10.45
-1.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Nurix Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
PE Ratio
-7.67 -2.35 -3.63 -10.55
PEG Ratio
-0.88 0.10 -0.14 9.70
PS Ratio
27.21 4.39 15.59 41.55
PB Ratio
2.82 1.69 1.98 3.61
P/FCF Ratio
-8.16 -3.77 -3.5 -13.73
P/OCF Ratio
-8.6 -4.15 -3.77 -14.65
OCF/S Ratio
-3.16 -1.06 -4.14 -2.84
Debt / Equity Ratio
0.05 0.15 0.04 0.04
Quick Ratio
6.46 3.40 4.52 4.70
Current Ratio
6.46 3.40 4.51 4.70
Asset Turnover
0.08 0.22 0.09 0.06
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.37 -0.72 -0.55 -0.34
Return on Assets
-0.29 -0.4 -0.4 -0.25
Return on Invested Capital
-0.37 -0.55 -0.47 -0.28
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.70 -1.46 0.72 0.80
Net Profit Margin
-3.55 -1.87 -4.3 -3.94
Pretax Profit Margin
-3.54 -1.87 -4.67 -3.93
Operating Profit Margin
-3.91 -2.01 -4.76 -3.96
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-3.6 -1.84 -4.48 -3.76